No abstract available
Keywords:
adverse effects; bioavailability; extended release; paliperidone palmitate; polymeric nanoparticles; risperidone.
Publication types
-
Editorial
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Antipsychotic Agents / administration & dosage*
-
Brain / metabolism
-
Humans
-
Mental Disorders / drug therapy*
-
Mental Disorders / metabolism
-
Nanomedicine*
-
Signal Transduction